Eldepryl

Active Ingredient(s): Selegiline
FDA Approved: * May 15, 1996
Pharm Company: * SOMERSET
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Eldepryl Overview

Selegiline, also known as L-deprenyl, is a substituted phenethylamine. At normal clinical doses, it is a selective irreversible MAO-B inhibitor. In larger doses it loses its specificity and also inhibits MAO-A. It is available in pill form under many brand names[1] and is used to reduce symptoms in early-stage Parkinson's disease. A transdermal patch (brand name, Emsam) is used to treat depression. .mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .to...

Read more Eldepryl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Selegiline

Recent Eldepryl Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Selegiline
  • Capsule: 5mg
  • Film, Extended Release: 12mg/24hr, 6mg/24hr, 9mg/24hr
  • System: 12mg, 6mg, 9mg
  • Tablet: 1.25mg, 5mg
  • Tablet, Orally Disintegrating: 1.25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Eldepryl: (3 results)

Sorted by National Drug Code
  • 39506-011 Eldepryl 5 mg Oral Tablet by Somerset Pharmaceuticals Inc.
  • 39506-022 Eldepryl 5 mg Oral Capsule by Somerset Pharmaceuticals Inc.
  • 49502-420 Eldepryl 5 mg Oral Capsule by Mylan Specialty

Other drugs which contain Selegiline or a similar ingredient: (4 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA